ROPIVACAINE VIATRIS 2 mg/ml, solution for injection in an ampoule 5 ampoules of 10 ml
Active ingredients: Ropivacaine hydrochloride, ROPIVACAÏNE BASE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 ampoules of 10 mlinfiltration;péridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROPIVACAINE VIATRIS 2 mg/ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;péridurale;périneurale
- Presentation description
- 5 ampoule(s) polypropylène suremballée(s)/surpochée(s) de 10 ml
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jan 2010
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66739091CIP75745064CIP133400957450649Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROPIVACAÏNE BASEsolution | 1,77 mg · 1 ml de solution injectable | FT |
| CHLORHYDRATE DE ROPIVACAÏNE ANHYDREsolution | 2 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.